01—Abstract
Summary
Summary of the 8-K filed July 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Natera, Inc. (NTRA) filed a Form 8-K dated July 6, 2026, reporting an event of July 1, 2026.
The filing is limited to a single Item 5.02 disclosure concerning board composition. It states that on July 1, 2026, Monica Bertagnolli notified the Board of Directors of her intention to resign from the Board and all of its committees, effective July 1, 2026, citing her new position with the National Academy of Medicine. The filing explicitly states that Ms. Bertagnolli's resignation was not the result of any disagreement with the Company on matters relating to its operations, policies or practices.
The report contains no financial results, operational updates, or compensation changes, and it does not name a replacement director. For investors, this is a routine governance change with no stated financial impact. The primary item to monitor is whether the Board announces a successor or changes to committee composition in subsequent filings.
02—Key points
Key Highlights
- Monica Bertagnolli notified the Board on July 1, 2026, of her intention to resign from the Board and all committees, effective the same day.
- The stated reason for the resignation is her new position with the National Academy of Medicine.
- The filing states the resignation was not due to any disagreement with the Company on operations, policies or practices.
- The 8-K is filed under Item 5.02 (Departure of Directors or Certain Officers) and contains no financial statements or results.
- No replacement director or new appointment is disclosed in this filing.
- The company is an emerging growth company per the cover page check box, and its common stock trades on the Nasdaq Global Select Market under the symbol NTRA.
03—Questions
Frequently Asked Questions
Why did the Natera board member resign?
According to the filing, Monica Bertagnolli resigned due to her new position with the National Academy of Medicine. The filing states the resignation was not related to any disagreement with the Company.
When did the resignation take effect?
The resignation was effective July 1, 2026, the same date she notified the Board of her intention to resign.
Did the resignation involve any disagreement with the company?
No. The filing explicitly states that the resignation was not the result of any disagreement with Natera on any matter relating to its operations, policies or practices.
Does this filing include financial results or guidance?
No. The 8-K reports only the director resignation under Item 5.02 and contains no financial statements, results, or guidance.
Has Natera named a replacement for Ms. Bertagnolli?
This filing does not identify any replacement director or committee appointments.
04—Continue